These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 20926077)

  • 1. Anti-inflammatory salicylate beneficially modulates pre-existing atherosclerosis through quenching of NF-κB activity and lowering of cholesterol.
    de Vries-van der Weij J; Toet K; Zadelaar S; Wielinga PY; Kleemann R; Rensen PC; Kooistra T
    Atherosclerosis; 2010 Nov; 213(1):241-6. PubMed ID: 20926077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of low dose atorvastatin versus diet-induced cholesterol lowering on atherosclerotic lesion progression and inflammation in apolipoprotein E*3-Leiden transgenic mice.
    Verschuren L; Kleemann R; Offerman EH; Szalai AJ; Emeis SJ; Princen HM; Kooistra T
    Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):161-7. PubMed ID: 15514207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual PPARalpha/gamma agonist tesaglitazar reduces atherosclerosis in insulin-resistant and hypercholesterolemic ApoE*3Leiden mice.
    Zadelaar AS; Boesten LS; Jukema JW; van Vlijmen BJ; Kooistra T; Emeis JJ; Lundholm E; Camejo G; Havekes LM
    Arterioscler Thromb Vasc Biol; 2006 Nov; 26(11):2560-6. PubMed ID: 16931788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fenofibrate reduces atherogenesis in ApoE*3Leiden mice: evidence for multiple antiatherogenic effects besides lowering plasma cholesterol.
    Kooistra T; Verschuren L; de Vries-van der Weij J; Koenig W; Toet K; Princen HM; Kleemann R
    Arterioscler Thromb Vasc Biol; 2006 Oct; 26(10):2322-30. PubMed ID: 16873727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptide inhibitor of NF-κB translocation ameliorates experimental atherosclerosis.
    Mallavia B; Recio C; Oguiza A; Ortiz-Muñoz G; Lazaro I; Lopez-Parra V; Lopez-Franco O; Schindler S; Depping R; Egido J; Gomez-Guerrero C
    Am J Pathol; 2013 May; 182(5):1910-21. PubMed ID: 23597852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epicatechin attenuates atherosclerosis and exerts anti-inflammatory effects on diet-induced human-CRP and NFκB in vivo.
    Morrison M; van der Heijden R; Heeringa P; Kaijzel E; Verschuren L; Blomhoff R; Kooistra T; Kleemann R
    Atherosclerosis; 2014 Mar; 233(1):149-56. PubMed ID: 24529136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined treatment with olmesartan medoxomil and amlodipine besylate attenuates atherosclerotic lesion progression in a model of advanced atherosclerosis.
    Sievers P; Uhlmann L; Korkmaz-Icöz S; Fastner C; Bea F; Blessing E; Katus HA; Preusch MR
    Drug Des Devel Ther; 2015; 9():3935-42. PubMed ID: 26251572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rosuvastatin reduces atherosclerosis development beyond and independent of its plasma cholesterol-lowering effect in APOE*3-Leiden transgenic mice: evidence for antiinflammatory effects of rosuvastatin.
    Kleemann R; Princen HM; Emeis JJ; Jukema JW; Fontijn RD; Horrevoets AJ; Kooistra T; Havekes LM
    Circulation; 2003 Sep; 108(11):1368-74. PubMed ID: 12939225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acyl-CoA:cholesterol acyltransferase inhibitor avasimibe reduces atherosclerosis in addition to its cholesterol-lowering effect in ApoE*3-Leiden mice.
    Delsing DJ; Offerman EH; van Duyvenvoorde W; van Der Boom H; de Wit EC; Gijbels MJ; van Der Laarse A; Jukema JW; Havekes LM; Princen HM
    Circulation; 2001 Apr; 103(13):1778-86. PubMed ID: 11282910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heat shock protein 90 inhibitors attenuate inflammatory responses in atherosclerosis.
    Madrigal-Matute J; López-Franco O; Blanco-Colio LM; Muñoz-García B; Ramos-Mozo P; Ortega L; Egido J; Martín-Ventura JL
    Cardiovasc Res; 2010 May; 86(2):330-7. PubMed ID: 20154064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-inflammatory, anti-proliferative and anti-atherosclerotic effects of quercetin in human in vitro and in vivo models.
    Kleemann R; Verschuren L; Morrison M; Zadelaar S; van Erk MJ; Wielinga PY; Kooistra T
    Atherosclerosis; 2011 Sep; 218(1):44-52. PubMed ID: 21601209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antiatherosclerotic mechanism of aspirin: experiment with rabbits].
    Yang XY; Wang L; Zhou N; Zeng HS
    Zhonghua Yi Xue Za Zhi; 2007 Dec; 87(46):3298-301. PubMed ID: 18396630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melatonin ameliorates vascular endothelial dysfunction, inflammation, and atherosclerosis by suppressing the TLR4/NF-κB system in high-fat-fed rabbits.
    Hu ZP; Fang XL; Fang N; Wang XB; Qian HY; Cao Z; Cheng Y; Wang BN; Wang Y
    J Pineal Res; 2013 Nov; 55(4):388-98. PubMed ID: 24006943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resveratrol protects against atherosclerosis, but does not add to the antiatherogenic effect of atorvastatin, in APOE*3-Leiden.CETP mice.
    Berbée JF; Wong MC; Wang Y; van der Hoorn JW; Khedoe PP; van Klinken JB; Mol IM; Hiemstra PS; Tsikas D; Romijn JA; Havekes LM; Princen HM; Rensen PC
    J Nutr Biochem; 2013 Aug; 24(8):1423-30. PubMed ID: 23337345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poly(ADP-ribose) polymerase inhibition reduces atherosclerotic plaque size and promotes factors of plaque stability in apolipoprotein E-deficient mice: effects on macrophage recruitment, nuclear factor-kappaB nuclear translocation, and foam cell death.
    Oumouna-Benachour K; Hans CP; Suzuki Y; Naura A; Datta R; Belmadani S; Fallon K; Woods C; Boulares AH
    Circulation; 2007 May; 115(18):2442-50. PubMed ID: 17438151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-atherosclerotic properties of telmisartan in advanced atherosclerotic lesions in apolipoprotein E deficient mice.
    Blessing E; Preusch M; Kranzhöfer R; Kinscherf R; Marx N; Rosenfeld ME; Isermann B; Weber CM; Kreuzer J; Gräfe J; Katus HA; Bea F
    Atherosclerosis; 2008 Aug; 199(2):295-303. PubMed ID: 18093593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiinflammatory and antiatherogenic effects of the NF-kappaB inhibitor acetyl-11-keto-beta-boswellic acid in LPS-challenged ApoE-/- mice.
    Cuaz-Pérolin C; Billiet L; Baugé E; Copin C; Scott-Algara D; Genze F; Büchele B; Syrovets T; Simmet T; Rouis M
    Arterioscler Thromb Vasc Biol; 2008 Feb; 28(2):272-7. PubMed ID: 18032778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parthenolide modulates the NF-kappaB-mediated inflammatory responses in experimental atherosclerosis.
    López-Franco O; Hernández-Vargas P; Ortiz-Muñoz G; Sanjuán G; Suzuki Y; Ortega L; Blanco J; Egido J; Gómez-Guerrero C
    Arterioscler Thromb Vasc Biol; 2006 Aug; 26(8):1864-70. PubMed ID: 16741149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of simvastatin on NF-kappaB-DNA binding activity and monocyte chemoattractant protein-1 expression in a rabbit model of atherosclerosis.
    Yang X; Wang L; Zeng H; Dubey L; Zhou N; Pu J
    J Huazhong Univ Sci Technolog Med Sci; 2006; 26(2):194-8. PubMed ID: 16850745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of chimeric decoy oligodeoxynucleotide in the regulation of transcription factors NF-κB and Sp1 in an animal model of atherosclerosis.
    Lee WR; Kim KH; An HJ; Park YY; Kim KS; Lee CK; Min BK; Park KK
    Basic Clin Pharmacol Toxicol; 2013 Apr; 112(4):236-43. PubMed ID: 23107157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.